Related Experiment Video
Updated: May 4, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition
Tiffany Jones1, Suzane Ramos da Silva2, Roble Bedolla3
1Department of Molecular Medicine; University of Texas Health Science Center at San Antonio; San Antonio, TX USA; Department of Molecular Microbiology and Immunology; Keck School of Medicine; University of Southern California; Los Angeles, CA USA.
Abstract:
Kaposi sarcoma-associated herpesvirus (KSHV) is a tumor virus encoding several proto-oncogenes. However, the roles of these viral genes in KSHV-induced tumorigenesis have not been defined. In this study, we used a recently developed model of KSHV-induced cellular transformation and tumorigenesis combining with a reverse genetic system to examine the role of a KSHV latent gene vCyclin (ORF72), a cellular Cyclin D2 homolog, in KSHV-induced oncogenesis. Deletion of vCyclin did not affect cell proliferation and cell cycle progression at a low-density condition, when cells were at an active proliferation state. However, vCyclin mutant cells were contact-inhibited and arrested at G 1 phase at a high-density condition. As a result, vCyclin mutant cells formed less and smaller colonies in soft agar assay. Nude mice inoculated with vCyclin mutant cells had reduced tumor incidence and extended tumor latency and survival compared with mice inoculated with wild-type (WT) virus-infected cells. WT but not mutant virus effectively induced Cyclin-dependent kinase inhibitor p27/Kip1 Ser10 phosphorylation and cytoplasmic relocalization. shRNA knockdown of p27 released the blockage of the mutant cells from cell cycle arrest at G 1 phase at a high-density condition. Together, these results indicate that vCyclin primarily functions to enhance cellular transformation and tumorigenesis by promoting cell cycle progression and cell proliferation at a contact-inhibited condition.
Insights
Kaposi sarcoma-associated herpesvirus (KSHV) vCyclin promotes cancer by overriding cell cycle arrest when cells are crowded. Deleting vCyclin reduces tumor formation and growth in mice.
Area of Science:
- Oncology
- Virology
- Cell Biology
Background:
- Kaposi sarcoma-associated herpesvirus (KSHV) is a tumor virus with oncogenic potential.
- The specific roles of KSHV-encoded proto-oncogenes in tumorigenesis remain largely undefined.
Purpose of the Study:
- To investigate the function of the KSHV latent gene vCyclin (ORF72), a homolog of cellular Cyclin D2, in KSHV-induced oncogenesis.
- To elucidate the mechanisms by which vCyclin contributes to cellular transformation and tumor development.
Main Methods:
- Utilized a KSHV-induced cellular transformation and tumorigenesis model combined with a reverse genetic system.
- Generated and analyzed vCyclin deletion mutants.
- Assessed cell proliferation, cell cycle progression, soft agar colony formation, and tumor development in nude mice.
- Investigated the phosphorylation and localization of p27/Kip1 and employed shRNA knockdown of p27.
Main Results:
- vCyclin deletion did not impact proliferation at low cell density but caused G1 arrest at high density.
- vCyclin mutant cells exhibited reduced soft agar colony formation.
- Mice inoculated with vCyclin mutant KSHV showed decreased tumor incidence, longer latency, and increased survival.
- Wild-type KSHV, but not mutant virus, induced p27/Kip1 phosphorylation and cytoplasmic relocalization; p27 knockdown rescued the mutant phenotype.
Conclusions:
- vCyclin is crucial for enhancing cellular transformation and tumorigenesis.
- vCyclin promotes cell cycle progression and proliferation, particularly under contact-inhibited conditions.
- The mechanism involves the regulation of p27/Kip1 activity and localization.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Anaphase Promoting Complex
Positive Regulator Molecules

